Zealand Pharma A/S (ZLDPF) News Today

Zealand Pharma A/S (OTCMKTS:ZLDPF - Free Report) - Cantor Fitzgerald issued their FY2024 EPS estimates for shares of Zealand Pharma A/S in a research note issued to investors on Tuesday, May 21st. Cantor Fitzgerald analyst P. Agrawal forecasts that the company will earn ($2.53) per share for the

Cantor Fitzgerald assumed coverage on Zealand Pharma A/S in a report on Tuesday. They set an "overweight" rating for the company.

Zealand Pharma A/S (OTCMKTS:ZLDPF) Shares Up 1.3%

Zealand Pharma A/S (OTCMKTS:ZLDPF - Get Free Report) was the target of a large growth in short interest in April. As of April 15th, there was short interest totalling 409,800 shares, a growth of 21.1% from the March 31st total of 338,500 shares. Based on an average trading volume of 4,000 shares, the days-to-cover ratio is currently 102.5 days.

Zealand Pharma A/S (OTCMKTS:ZLDPF) Stock Price Up 1.3%

Zealand Pharma A/S (OTCMKTS:ZLDPF) Trading 0.5% Higher

BTIG Research began coverage on shares of Zealand Pharma A/S in a research note on Thursday. They issued a "buy" rating on the stock.

Zealand Pharma A/S (OTCMKTS:ZLDPF) Reaches New 1-Year High at $71.94